United States · FDA National Drug Code directory
NYSTATIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69315-306_408ac13e-825a-44b1-b8cd-d52cbb0185d0
- Product NDC
- 69315-306
- Form
- POWDER
- Composition / generic term
- NYSTATIN
- Labeler
- Leading Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180423
- Source listing expiry
- 20261231
Source-listed ingredients
- NYSTATIN — 100000 [USP'U]/g
These values do not establish equivalence or a dose recommendation.
Packages
- 15 g in 1 BOTTLE, PLASTIC (69315-306-15) · 69315-306-15
- 30 g in 1 BOTTLE, PLASTIC (69315-306-30) · 69315-306-30
- 60 g in 1 BOTTLE, PLASTIC (69315-306-60) · 69315-306-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →